AbbVie Income from Continuous Operations 2012-2026 | ABBV

AbbVie income from continuous operations for the twelve months ending March 31, 2026 was $3.641B, a 13.37% decline year-over-year.

  • AbbVie annual income from continuous operations for 2025 was $4.233B, a 1.24% decline from 2024.
  • AbbVie annual income from continuous operations for 2024 was $4.286B, a 12.05% decline from 2023.
  • AbbVie annual income from continuous operations for 2023 was $4.873B, a 58.86% decline from 2022.

AbbVie Income from Continuous Operations 2012-2026 | ABBV

  • AbbVie annual income from continuous operations for 2025 was $4.233B, a 1.24% decline from 2024.
  • AbbVie annual income from continuous operations for 2024 was $4.286B, a 12.05% decline from 2023.
  • AbbVie annual income from continuous operations for 2023 was $4.873B, a 58.86% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B